108年論文發表

作者
論文題目
期刊名稱
論文屬性
田宇峯(3)
High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
Urol Oncol
2019 May
Vol 37/NO 5/P E7-E18
SCI
陳明鎮(C)
Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer.
Pathol Res Pract.
2019 Apr;215(4):801-806
SCI
孫定平(1)
Clinicopathologic and Prognostic Significance of Thymopoietin-α Overexpression in Gastric Cancer.
Journal Of Cancer
2019; 10(21): 5099–5107
SCI 
孫定平(6)
Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma.
World J Gastroenterol
2019 Jun 7;25(21):2636-2649
SCI
孫定平(6)
A longitudinal study of healthcare utilisation and expenditure in people with type 2 diabetes mellitus with and without major depressive disorder.
General Hospital Psychiatry
Volume 57, March–April 2019, Pages 50-58
 SCI
王文慶(5)
High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma.
Ther Adv Med Oncol.
2019 Vol. 11:1-14
 SCI
鄭立勤(1)
The Impact of High-Flow Nasal Cannula on the Outcome of Immunocompromised Patients with Acute Respiratory Failure: A Systematic Review and Meta-Analysis
Medicina (Kaunas)
2019 Oct; 55(10): 693.
SCI
周家麟(2)
Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy.
Int J Mol Sci
2019 Aug
21;20(17). pii: E4087.
SCI
田宇峯(3)
igher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression.
Oncol Lett
2019 Feb/17(2)/1551-8
-
孫定平(4)
Clinical and biological significance of thymopoietin-α in gastric cancer
ANN ONCOL
Volume 30, Supplement 6,
Pages vi1-vi148
- 
王家豪(2)
孫定平(3)
Solitary fibrous tumor of the liver with ivc encasement
A-PHPBA 2019 SEOUL
Volume 21, Supplement 2, Pages S354–S355
- 
黃至豪(1)
鄭立勤(3)
田宇峯(4)
周家麟(C)
Use of N(2)-L-Alanyl-L-Glutamine Dipeptide in Stage III Colon Cancer Patients with Oxaliplatin-based Chemotherapy, Benefit or Harm?
Soc Colon Rectal Surgeon
201912 Vol 30. no 4. 164-172
- 
李凱莉
Norma Gill Day Celebrations
WCET bulletin Vol16 No 3 Oct 2019 p40-41
-

列印